AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 37 filers reported holding AVENUE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,000 | -60.0% | 1,125 | -45.9% | 0.00% | – |
Q2 2021 | $5,000 | -85.3% | 2,078 | -62.7% | 0.00% | – |
Q1 2021 | $34,000 | +161.5% | 5,568 | +159.0% | 0.00% | – |
Q4 2020 | $13,000 | -60.6% | 2,150 | -28.8% | 0.00% | – |
Q3 2020 | $33,000 | -15.4% | 3,018 | -16.7% | 0.00% | – |
Q2 2020 | $39,000 | – | 3,625 | +32854.5% | 0.00% | – |
Q3 2019 | $0 | – | 11 | -72.5% | 0.00% | – |
Q1 2019 | $0 | – | 40 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 800,000 | $3,800,000 | 1.05% |
EAM Investors, LLC | 91,966 | $437,000 | 0.11% |
B. Riley Wealth Advisors, Inc. | 59,250 | $282,000 | 0.04% |
Frontier Wealth Management LLC | 20,000 | $95,000 | 0.01% |
Spark Investment Management LLC | 30,500 | $144,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 4,785 | $23,000 | 0.00% |
BlackRock Inc. | 16,939 | $80,000 | 0.00% |
Tower Research Capital LLC (TRC) | 408 | $2,000 | 0.00% |
DEUTSCHE BANK AG\ | 10,808 | $51,000 | 0.00% |